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Abstract
Introduction: Urinary indices have limited effectiveness in separating transient acute kidney injury (AKI) from
persistent AKI in ICU patients. Their time-course may vary with the mechanism of AKI. The primary objective of this
study was to evaluate the diagnostic value of changes over time of the usual urinary indices in separating transient
AKI from persistent AKI.
Methods: An observational prospective multicenter study was performed in six ICUs involving 244 consecutive
patients, including 97 without AKI, 54 with transient AKI, and 93 with persistent AKI. Urinary sodium, urea and creatinine
were measured at ICU admission (H0) and on 6-hour urine samples during the first 24 ICU hours (H6, H12, H18, and
H24). Transient AKI was defined as AKI with a cause for renal hypoperfusion and reversal within 3 days.
Results: Significant increases from H0 to H24 were noted in fractional excretion of urea (median, 31% (22 to 41%)
and 39% (29 to 48%) at H24, P < 0.0001), urinary urea/plasma urea ratio (15 (7 to 28) and 20 (9 to 40), P < 0.0001),
and urinary creatinine/plasma creatinine ratio (50 (24 to 101) and 57 (29 to 104), P = 0.01). Fractional excretion of
sodium did not change significantly during the first 24 hours in the ICU (P = 0.13). Neither urinary index values at
ICU admission nor changes in urinary indices between H0 and H24 performed sufficiently well to recommend their
use in clinical setting (area under the receiver-operating characteristic curve ≤0.65).
Conclusion: Although urinary indices at H24 performed slightly better than those at H0 in differentiating transient
AKI from persistent AKI, they remain insufficiently reliable to be clinically relevant.
Introduction
Acute kidney injury (AKI) affects approximately 5 to 30%
of critically ill patients and remains associated with high
mortality rates [1-3]. AKI not due to urinary tract obstruc-
tion is usually described as either transient or persistent.
Transient AKI is due to low renal perfusion and is
promptly reversible after normalization of the hemody-
namic parameters, whereas persistent AKI is believed
to be due to renal tubular damage or dysfunction [4-6].
Distinguishing transient AKI from persistent AKI may
help to optimize treatment decisions in patients with AKI.
Urinary indices such as the fractional excretion of sodium
(FeNa) and the fractional excretion of urea (FeUrea) are
believed to be reliable for separating transient AKI from
persistent AKI [4,5,7-9]. However, these indices may be
affected by diuretic agents or sepsis [10]. In addition, little
information is available on their performance for separat-
ing transient AKI from persistent AKI in critically ill
patients [11]. Urine or plasma biomarkers such as neutro-
phil gelatinase-associated lipocalin and IL-18 have been
evaluated as tools for distinguishing between transient
AKI and persistent AKI [12-15] but produced conflicting
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results and therefore cannot be recommended for wide-
spread use at present [13,16-18].
Hemodynamic and renal perfusion changes have been
shown to affect sodium excretion during the first 24
hours of sepsis in a sheep model [19]. Sepsis-associated
changes in urinary indices promptly returned to normal
after renal function recovery in these animals [19]. The
time-course of the urinary indices may thus differ
between patients with transient AKI and persistent AKI,
and evaluating changes over time may therefore improve
the urinary index performance in separating these two
mechanisms of AKI.
The primary objective of this study was to evaluate the
diagnostic value of changes over time of the usual urin-
ary indices in separating transient AKI from persistent
AKI. The secondary objectives were to evaluate the
diagnostic value of the usual urinary indices at ICU
admission and at 24 hours (H24) in separating transient
AKI from persistent AKI.
Materials and methods
Patients
The study was approved by the institutional review
board of the French Society for Intensive Care Medicine
(SRLF-CE-11-326), which waived the need for signed
informed consent, given the observational study design.
Patients and their next of kin were informed, and none
refused to participate in the study.
Six university-hospital ICUs in France participated in the
study between June 2011 and April 2012. Consecutive
adults admitted to these ICUs were included in the
absence of obstructive renal disease, renal replacement
therapy (RRT) for chronic renal dysfunction, and preg-
nancy. Patients for whom urine could not be collected
according to the study protocol were excluded secondarily;
as were patients with hospital stays shorter than 72 hours,
since they could not be classified as having transient AKI
or persistent AKI according to our definitions.
Definitions
AKI was defined according to the Acute Kidney Injury
Network classification scheme as a plasma creatinine level
increase ≥26.4 μmol/l, a plasma creatinine increase ≥150%
from baseline, or urine output < 0.5 ml/kg/hour for ≥6
hours [20]. For patients whose baseline plasma creatinine
level was unknown, this variable was estimated using
either the plasma creatinine nadir during the ICU stay or,
in patients who died before AKI resolution, the Modifica-
tion of Diet in Renal Disease formula [6,21,22].
Transient AKI was defined as AKI with a cause of renal
hypoperfusion according to the attending physician and
recovery within 3 days [6,11]. Recovery of AKI was defined
as reversal of the oliguria (in the absence of diuretic treat-
ment) and/or ≥50% decrease in plasma creatinine and/or a
return of plasma creatinine to the baseline value (whether
measured or estimated using the Modification of Diet in
Renal Disease formula) [11,23]. For patients having both
oliguria and plasma creatinine changes defining AKI, both
correction of plasma creatinine and oliguria were required
to define recovery. Persistent AKI was defined as renal
dysfunction without recovery within 3 days. Oliguria was
defined as urine output < 0.5 ml/kg/hour for ≥6 hours
[11,23].
Diuretic use at every time of this study was defined as
use of diuretics in the 6 hours preceding urinary indices
measurement.
Changes in urinary indices between ICU admission
(H0) and H24 are reported as the ratio between urinary
indices at H0 by urinary indices at H24
Data collection
Each patient was assessed during the first 6 hours follow-
ing ICU admission. Plasma sodium, urea, and creatinine
levels were collected at ICU admission and then on days 1,
2, and 3. Urinary sodium, potassium, urea, and creatinine
were measured at H0 and then on four consecutive
6-hour urine samples (H6, H12, H18, and H24). Urinary/


















Plasma sodium, creatinine, and urea concentrations
used for the calculations were those obtained closest in
time to the urine sample.
The Logistic Organ Dysfunction score, the Simplified
Acute Physiology Score version II and the Knaus scale
score were calculated at ICU admission [24-26]. Sepsis
was diagnosed using the criteria developed at the Ameri-
can College of Chest Physicians/Society of Critical Care
Medicine consensus conference [27]. Individual organ fail-
ure was defined as a Logistic Organ Dysfunction score > 1
point for the relevant system, except the kidney [24].
Diuretic use was defined as the use of diuretics at any time
during the first 24 hours in the ICU.
Statistical analysis
Changes, as percentages, are described as the mean ± stan-
dard deviation and other data as the median (interquartile
range) or number (percentage). Categorical variables were
compared using Fisher’s exact test and continuous vari-
ables using the nonparametric Wilcoxon test, Mann-Whit-
ney test, or Kruskal-Wallis test. The Friedman test was
used to compare continuous variables across the three
patient groups (no AKI, transient AKI, and persistent
AKI) and to evaluate changes in urinary index values over
time.
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To assess the performance of urinary indices or their
changes over the first 24 hours in distinguishing transient
AKI from persistent AKI, we plotted the receiver-operat-
ing characteristic curves for the proportion of true posi-
tives against the proportion of false positives, depending
on the prediction rule used to classify patients as having
persistent AKI. The same strategy was used to assess the
performance of indices and their changes over time in
two predefined patient subgroups; namely, patients who
did not receive diuretic therapy and patients without
sepsis.
All tests were two-sided, and P < 0.05 was considered
statistically significant. Statistical tests were carried out




During the study period, 244 patients with a median age
of 63 years (52 to 73 years) were included. Their main
characteristics are reported in Table 1. According to our
definitions, 97 patients had no AKI (39.8%), 54 patients
(22.1%) had transient AKI, and 93 patients (38.1%) had
persistent AKI.
At ICU admission, the median Simplified Acute Phy-
siology Score version II was 44 (33 to 55) and the median
LOD score was 5 (4 to 8). Most patients were admitted
for medical conditions (n = 224, 91.9%). The main risk
factors for AKI were sepsis (49.8%), exposure to contrast
agents (31.1%), diabetes mellitus (19.3%), aminoglycoside
therapy (10.2%), and chronic kidney disease (6.1%).
No patient was receiving RRT t the time of the study.
RRT was required during the ICU stay in 21 patients
(8.6%), usually during the first 24 hours in the ICU (n =
14/244, 5.7%).
Urinary indices at ICU admission
Table 1 and Figure 1 report the main urinary index
values at ICU admission. Median FeNa, FeUrea, and U/P
ratios of urea and creatinine differed significantly across
the groups with no AKI, transient AKI, and persistent
AKI.
Changes in urinary indices during the first 24 hours after
ICU admission in the overall population
Significant increases were noted between H0 and H24 in
FeUrea (from 31% (22 to 41%) to 39% (29 to 48%), P <
0.0001), in U/P urea ratio (from 15 (7 to 28) to 20 (9 to
40), P < 0.0001), and in U/P creatinine ratio (from 50 (24
to 101) to 57 (29 to 104), P = 0.01) (Figure 2; Table S1 in
Additional file 1). FeNa did not change significantly (P =
0.13) during the first 24 hours in the ICU.
Changes in urinary indices during the first 24 hours after
ICU admission in the groups without AKI, with transient
AKI, and with persistent AKI
In the group with transient AKI, FeUrea increased signifi-
cantly from H0 to H24 (from 29% (21 to 39%) to 42% (30
to 51%), P < 0.001) (Figure 2; Table S1 in Additional
file 1). No significant changes in FeUrea occurred in the
group with persistent AKI (P = 0.08). In none of the three
groups did FeNa or the U/P creatinine ratio change signifi-
cantly. The U/P urea ratio increased significantly in both
AKI groups (transient AKI, from 11 (7 to 22) to 29 (10 to
42), P < 0.0001; and persistent AKI, from 10 (4 to 19) to
13 (6 to 27), P < 0.0001).
Changes in urinary indices in patients with and without
diuretic therapy are reported in Table S2 and Figures S1
and S2 in Additional file 1.
Performance of urinary indices and their changes in
differentiating transient from persistent acute kidney
injury
Table 2 reports the performance data for the urinary
indices. None of the four urinary indices at ICU admis-
sion differentiated transient AKI from persistent AKI in
the overall population (area under the receiver-operating
characteristic curve 0.50 to 0.59) or in the subgroups
without diuretic therapy or without sepsis. Compared
with values at ICU admission, values at H24 and changes
from H0 to H24 performed slightly better; however, their
performance remained too poor to be clinically relevant
(area under the receiver-operating characteristic curve
≤0.65 for all values; Table 2). The main factors associated
with persistent AKI after adjustment for confounders are
reported in Table S3 in Additional file 1.
Discussion
To the best of our knowledge, this is the first study evalu-
ating the time-course of standard urinary indices (FeNa,
FeUrea, U/P urea, and U/P creatinine) in critically ill
patients without AKI, with transient AKI, and with per-
sistent AKI. The indices were not effective in differentiat-
ing transient AKI from persistent AKI. Most of them
changed significantly over the first 24 hours in the ICU,
but these changes did not accurately separate transient
from persistent AKI.
Urinary index values at ICU admission performed poorly
for differentiating transient and persistent AKI. Although
many publications advocate the use of these indices, few
of them focus on critically ill patients or patients with sep-
sis [4,5,7,8]. In addition, most of the available studies are
single-center case series or retrospective cohort studies
[28-31]. The definitions of AKI and transient AKI varied
across studies, and most definitions of transient AKI relied
on subjective criteria [28-31]. Finally, these studies
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included patients who did not have critical illnesses
[9,31,32]. In our study, we used an objective definition of
transient AKI. Most of the study patients had sepsis at
ICU admission, a condition associated with alterations in
renal handling of sodium and water despite normal renal
perfusion or adequate fluid therapy [19]. This point may
explain the differences between our results and those of
previous studies [9,28,30-32]. Interestingly, FeNa and
FeUrea were usually decreased in both transient AKI and
persistent AKI [11,19], suggesting partial preservation of
tubular function even in patients with persistent AKI
[19,23]. In critically ill patients, therefore, urinary indices
may be unable to distinguish transient AKI from persistent
AKI.
The main objective of this study was to evaluate the
diagnostic performance of urinary index changes over the
first 24 hours in the ICU for separating transient AKI and
persistent AKI. In sheep, FeNa declined within the first
few hours after the induction of septic AKI and then
returned to normal during renal recovery [19]. Similarly,
urinary indices returned to normal within 24 hours in
our patients, and the improvement was more rapid in the
transient AKI group than in the persistent AKI group. As
a result, H24 values performed significantly better than
Table 1 Characteristics of patients without acute kidney injury (AKI), with transient AKI, and with persistent AKI
No AKI (n = 97) Transient AKI (n = 54) Persistent AKI (n = 93) P valuea
Patient characteristics
Male gender 56 (57.7) 34 (62.9) 66 (71.0) 0.16
Age (years) 60 (49 to 70) 65 (52 to 74) 67 (56 to 76) 0.02
Knaus C or D 30 (30.9) 18 (35.3) 31 (36.0) 0.73
LOD score at admission 4 (2 to 7) 5 (3 to 8) 6 (4 to 9) 0.006
SAPS II score at admission 41 (31 to 54) 43 (34 to 52) 46 (36 to 59) 0.06
Baseline plasma creatinine (μmol/l) 55 (45 to 65) 56 (44 to 69) 65 (53 to 89) 0.0006
Risk factors for AKI
Chronic heart failure 11 (11.3) 11 (20.3) 18 (19.4) 0.22
Chronic kidney diseaseb 2 (2.1) 1 (1.9) 12 (12.9) 0.02
Sepsis 36 (38.7) 32 (60.4) 48 (55.2) 0.02
Aminoglycosides 6 (6.7) 7 (14.6) 12 (14.0) 0.22
Ionidated contrast agents 37 (41.1) 11 (22.9) 22 (25.3) 0.03
Diabetes mellitus 8 (8.3) 15 (27.8) 24 (25.8) 0.002
Reason for ICU admission
Acute respiratory failure 24 (24.7) 17 (31.5) 19 (20.5) 0.32
Coma 36 (37.1) 8 (14.8) 15 (16.1) 0.0006
Sepsis/shock 13 (13.4) 19 (35.2) 43 (46.3) < 0.0001
Treatments
Need for vasoactive drugs 80 (51.6) 25 (46.3) 55 (59.1) 0.29
Mechanical ventilation 79 (81.4) 30 (55.6) 55 (59.4) 0.0006
Renal replacement therapy 1 (1.0) 0 13 (14.0) < 0.0001
Diuretics 30 (30.9) 17 (31.5) 33 (35.5) 0.78
Renal function at admission
Diuresis (ml/kg/hour) 1.29 (0.69 to 1.99) 1.14 (0.73 to 2.00) 0.79 (0.48 to 1.22) 0.0005
Plasma urea (mmol/l) 5.9 (4.4 to 8.1) 10.8 (7.3 to 14.9) 14.1 (7.6 to 25.2) < 0.0001
Plasma creatinine (μmol/l) 64 (53 to 80) 111 (76 to 170) 139 (95 to 253) < 0.0001
Urinary indices
FeNa (%) 0.7 (0.2 to 1.7) 0.8 (0.3 to 2.7) 1.1 (0.4 to 2.8) 0.03
FeUrea (%) 35 (24 to 45) 29 (21 to 39) 29 (21 to 36) 0.03
U/P urea 23 (14 to 34) 11 (7 to 22) 10 (4 to 19) < 0.0001
U/P creatinine 70 (39 to 129) 37 (17 to 98) 38 (17 to 74) < 0.0001
Outcome
ICU mortality 22 (22.7) 12 (22.2) 21 (22.5) 0.99
Hospital mortality 25 (25.8) 17 (31.5) 26 (28.0) 0.56
Results reported as median (interquartile range) or n (%). FeNa, fractional excretion of sodium ([U/P sodium]/[U/P creatinine])×100; FeUrea, fractional excretion of
urea ([U/P urea]/[U/P creatinine])×100; LOD, Logistic Organ Dysfunction score (can range from 0 to 22); SAPS, Simplified Acute Physiology Score; U/P,
urinary/plasma. aP values are for comparisons across the three patient groups. bChronic renal failure was defined as creatinine clearance before ICU admission
< 60 ml/minute. Bold data represent variables that differ statistically across groups of patients.
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H0 values in differentiating transient AKI from persistent
AKI. Nevertheless, performance of the H24 values
remained too low to be clinically relevant.
Interestingly, diuretic therapy had no effect on urinary
indices or their changes over time in our study. In parti-
cular, FeNa changes over the first 24 hours were not
significantly different in the groups with and without
diuretic therapy. Resistance to diuretics may explain this
finding. Heart failure, renal hypoperfusion related to
shock or sepsis, and hypoalbuminemia are common in
ICU patients and can result in resistance to diuretics
[33,34]. In patients given diuretics before ICU admis-
sion, rebound sodium retention, a post-diuretic effect,
and diuretic braking also contribute to diuretic resis-
tance [35,36]. Last, our patients received diuretics as
bolus injections. Using continuous infusions [37,38] or
higher dosages might have produced different results.
Our study has several limitations. First, our definition
of transient AKI was based on renal function recovery.
Indeed, a more selective definition of pre-renal AKI
would have required the use of highly subjective criteria
such as clinical history, physical examination, and physi-
cian judgment [9,10]. We elected to use a definition that
relied on an objective criterion. In addition, our defini-
tion takes into account the continuum that probably
exists between renal hypoperfusion and kidney damage
[6]. The difference between our definition of transient
AKI and that used in earlier studies may contribute to
the discrepancies in the results. Moreover, our definition
was highly sensitive for detecting patients with transient
AKI, since none of these patients required RRT, but also
lacked specificity, as less than 20% of patients with per-
sistent AKI required RRT. This limitation must be taken
into account when interpreting our results. In addition,
1a. 1b.
1c. 1d.
Figure 1 Boxplot representation of urinary indices at baseline according to renal function. (a) Fractional excretion of urea (FeUrea)
according to renal function (P = 0.03). (b) Fractional excretion of sodium (FeNa) according to renal function (P = 0.03). (c) The urine/plasma (U/
P) urea ratio according to renal function (P < 0.0001). (d) The U/P creatinine ratio according to renal function (P < 0.0001). AKI, acute kidney
injury. Whiskers represent 5th to 95th percentiles.
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2a. 2b.
2c. 2d.
Figure 2 Changes in urinary indices during the first 24 hours after ICU admission according to renal function. (a) Fractional excretion of
urea (FeUrea) according to renal function. (b) Fractional excretion of sodium (FeNa) according to renal function. (c) The urine/plasma (U/P) urea
ratio according to renal function. (d) The U/P creatinine ratio according to renal function. AKI, acute kidney injury; H0, ICU admission; H6, H12,
H18, and H24, 6-hour urine samples during the first 24 ICU hours. Data presented as mean ± 95% confidence interval.
Table 2 Diagnostic performance of and changes in urinary indices at ICU admission and after 24 hours
Patients with AKI Overall population (n = 147) Patients without diuretics (n = 97) Patients without sepsis(n = 60)
Urinary indices at ICU admission
FeNa 0.59 (0.49 to 0.69) 0.54 (0.41 to 0.66) 0.59 (0.42 to 0.75)
FeUrea 0.50 (0.41 to 0.60) 0.53 (0.41 to 0.65) 0.64 (0.49 to 0.79)
U/P urea 0.57 (0.48 to 0.67) 0.56 (0.45 to 0.68) 0.59 (0.45 to 0.74)
U/P creatinine 0.55 (0.45 to 0.65) 0.53 (0.41 to 0.65) 0.61 (0.46 to 0.77)
Urinary indices at H24
FeNa 0.61 (0.51 to 0.71) 0.64 (0,52 to 0,76)* 0,56 (0,40 to 0.72)
FeUrea 0.51 (0.40 to 0.62) 0.57 (0.43 to 0.70) 0.56 (0.39 to 0.72)
U/P urea 0.65 (0.55 to 0.75)* 0.65 (0.53 to 0.76)* 0.67 (0.51 to 0.83)*
U/P creatinine 0.58 (0.48 to 0.69) 0.56 (0.43 to 0.69) 0.58 (0.41 to 0.76)
Changes in urinary indices between H0 and H24
FeNa 0.59 (0.49 to 0.70) 0.58 (0.45 to 0.71) 0,59 (0,40 to 0.78)
FeUrea 0.57 (0.47 to 0.68)* 0.58 (0.44 to 0.72) 0.61 (0.43 to 0.78)
U/P urea 0.61 (0.51 to 0.71)* 0.60 (0.47 to 0.73) 0.65 (0.48 to 0.81)
U/P creatinine 0.51 (0.49 to 0.62) 0.52 (0.40 to 0.65) 0.53 (0.33 to 0.70)
Diagnostic performance of urinary indices at ICU admission and after 24 hours, and changes in urinary indices over the first 24 hours in the ICU for separating
transient from persistent acute kidney injury. Data are areas under the receiver-operating characteristic curves (± 95%). AKI, acute kidney injury; FeNa, fractional
excretion of sodium ([U/P sodium]/[U/P creatinine])×100; FeUrea, fractional excretion of urea ([U/P urea]/[U/P creatinine])×100; H0, ICU admission; H24, 24 hours;
U/P, urinary/plasma. *P < 0.05. Bold data represent AUC that differ statistically from 0.5.
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an imbalance of the case mix across the three groups of
patients (no AKI, transient AKI and persistent AKI) was
observed. Patients without AKI were thus more fre-
quently admitted for neurological dysfunction than
patients with AKI usually admitted with severe sepsis or
septic shock. This may explain the higher rate of
mechanical ventilation in patients without AKI than
patients with AKI and the absence of association between
mortality and AKI in this study. However, performance
of urinary indices in this study is consistent with previous
studies performed in different ICUs or in populations
with a different case mix [11,15]. Another limit of our
study was that neither fluid balance nor fluid therapy was
recorded. We may suppose that both these variables
could influence the final results.
Although our study suggests that none of the usual urin-
ary indices or their changes may reliably help in distin-
guishing transient AKI from persistent AKI, further
studies are needed to assess influence of fluid challenge
and fluid balance on urinary index course or performance.
Last, we did not evaluate newly described biomarkers for
diagnosing transient AKI. Future studies should compare
these biomarkers with the standard urinary indices evalu-
ated in our study.
Conclusion
This study confirms the poor performance of standard
urinary indices at ICU admission for differentiating transi-
ent AKI from persistent AKI in unselected critically ill
patients. Although changes over the first 24 hours and
values at H24 performed slightly better than values at
admission, their performance remained too low to be
clinically useful. Additional studies are needed to identify
means of reliably separating transient and persistent AKI,
with the goal of improving early therapeutic interventions.
Key messages
• Standard urinary index values at ICU admission
performed poorly for differentiating transient AKI
and persistent AKI.
• Although changes over the first 24 hours and
values at H24 performed slightly better than values
at admission, their performance remained too low to
be clinically useful.
• Performance of newest biomarkers in this setting
remains to be evaluated.
Additional material
Additional file 1: Table S1 showing changes in urinary indices
during the first 24 hours following ICU admission and Table S2
showing the influence of diuretic therapy. Table S3 showing factors
independently associated with persistent AKI in a conditional logistic
regression model. Figure S1 showing changes in urinary indices in the
overall population, in patients receiving diuretic therapy during the first
24 hours following ICU admission and in patients without diuretic
therapy. Figure S2 showing change in urinary indices according to renal
function and use of diuretics.
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